It is used to to qualitatively detect Dengue virus non-structural protein 1 (NS1 Ag) in human serum, plasma, or whole blood samples, supporting the early preliminary screening of Dengue virus infection.
It is used to detect both human immunodeficiency virus (HIV) antigens (primarily p24 antigen) and antibodies (against HIV-1 and HIV-2) in human serum, plasma, or whole blood samples, enabling earlier preliminary screening of HIV infection compared to antibody-only tests.
It is used to detect the specific antigens of Plasmodium falciparum (Pf.) and Plasmodium vivax (Pv.)—two common pathogenic Plasmodium species—in human whole blood samples, supporting the targeted preliminary screening of malaria infections caused by these two Plasmodium species.
It is used to detect the specific antigens of Plasmodium falciparum (Pf.), the most pathogenic Plasmodium species, in human whole blood samples, aiding in the targeted preliminary screening of Plasmodium falciparum-caused malaria infections.
It is used to detect Plasmodium antigens (covering common Plasmodium species like Plasmodium falciparum, Plasmodium vivax, etc.) in human whole blood samples, assisting in the preliminary screening of malaria infections.
It is used to to qualitatively detect the antigens of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, the pathogen causing COVID-19) and Influenza A/B viruses in human nasopharyngeal or oropharyngeal swab samples, facilitating the differential preliminary screening of COVID-19 and Influenza A/B infections.
It is used to to qualitatively detect antibodies against Hepatitis C Virus (HCV) in human serum, plasma, or whole blood, aiding in the preliminary screening of HCV infection.